http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103945849-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77d5c58217c181eed0f7a3189fb3141f |
| publicationDate | 2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103945849-A |
| titleOfInvention | Combination Therapy for Cancer |
| abstract | The present invention relates to a combination drug comprising: AZD5363 or a pharmaceutically acceptable salt thereof, and a drug selected from MDV-3100 (also known as enzalutamide (enzalutamide)), AZD3514, abiraterone (or its ester precursor Drug: at least one androgen receptor signaling modulator such as abiraterone acetate) and bicalutamide or a pharmaceutically acceptable salt thereof. Each of these combinations can be used in the treatment of cancer. The present invention also relates to pharmaceutical compositions comprising such combinations, and also to methods of treatment comprising combining AZD5363 or a pharmaceutically acceptable salt thereof with at least one androgen receptor signaling modulator as described above. The agents are administered simultaneously, sequentially or separately to a warm-blooded animal such as a human to treat cancer. The invention also relates to a kit comprising this combination. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108486041-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111107852-A |
| priorityDate | 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.